{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:40:36Z","timestamp":1698540036908},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:00:00Z","timestamp":1228867200000},"content-version":"vor","delay-in-days":4027,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Concanavalin A (ConA) activates T lymphocytes and causes T\u2010cell mediated hepatic injury in mice. The intravenous administration of human immunoglobulins has beneficial effects in T\u2010cell mediated diseases such as experimental autoimmune encephalomyelitis and adjuvant arthritis. In the present study, we examined the effects of intravenous immunoglobulins in a mouse model of T\u2010cell mediated, acute liver injury induced by concanavalin A. Balb\/c mice were inoculated with 12 mg\/kg concanavalin A with or without intravenous immunoglobulins at doses of 0.4, 0.6, 0.8 g\/kg body wt. The serum levels of liver enzymes, tumor necrosis factor\u2010\u03b1, interferon\u2010\u03b3 and interleukin\u20106 were assayed 2, 6 and 24 h after concanavalin A administration. Intravenous immunoglobulins did not prevent concanavalin A\u2010induced hepatitis, as manifested by elevation of serum aminotransferases and histopathological evaluation. The serum levels of tumor necrosis factor\u2010\u03b1 in mice pretreated with immunoglobulins, measured 2 h after ConA treatment were reduced, while interferon\u2010\u03b3 levels measured 6 h after ConA inoculation were 5\u2010fold higher than control levels. There was no effect of intravenous immunoglobulins on the release of interleukin 6. In conclusion, these results indicate that intravenous immunoglobulin is not effective in preventing T\u2010cell mediated concanavalin A\u2010induced hepatitis. The increased secretion of interferon\u2010\u03b3 and the incomplete suppression of tumor necrosis factor\u2010\u03b1 release may explain the lack of efficacy of intravenous immunoglobulin in this experimental model.<\/jats:p>","DOI":"10.1111\/j.1600-0676.1997.tb01032.x","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T19:47:51Z","timestamp":1281469671000},"page":"275-280","source":"Crossref","is-referenced-by-count":7,"title":["Effects of intravenous immunoglobulins on T\u2010cell mediated, concanavalin A\u2010induced hepatitis in mice"],"prefix":"10.1111","volume":"17","author":[{"given":"Haim","family":"Shirin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Aeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Hershkoviz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Lider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Kenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Avni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamir","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"140","article-title":"Clinical uses of intravenous immunoglobulins","volume":"25","author":"Berkman S A","year":"1988","journal-title":"Semin Hematol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1001\/jama.1990.03450240091046","article-title":"Intravenous immunoglobulin prevention and treatment of diseases","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260206"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.10.1639"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.5.382"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530360031013"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117012"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1989.tb00031.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(92)90045-P"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(92)90044-O"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115836"},{"key":"e_1_2_1_13_2","first-page":"190","article-title":"Concanavalin A induced T cell mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner F.","year":"1995","journal-title":"Hepatology"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.5.1529"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240338"},{"key":"e_1_2_1_16_2","first-page":"1608","article-title":"Critical involvement of interferon gamma in the pathogenesis of T\u2010cell activation associated hepatitis and regulatory mechanisms of interleukin\u20106 for the manifestations of hepatitis","volume":"23","author":"Mizuhara H.","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8690213"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1203\/00006450-199404000-00004","article-title":"Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor\u2010\u03b1 production in vitro","volume":"35","author":"Darville T.","year":"1994","journal-title":"Pediatr Res"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250521"},{"key":"e_1_2_1_20_2","first-page":"372","article-title":"Human intravenous immunoglobulin modulates monokine production in vitro","volume":"71","author":"Andersson J P","year":"1990","journal-title":"Immunology"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood.V84.7.2136.2136","article-title":"Release of cytokines, soluble cytokine receptors and interleukin\u20101 receptor antagonist after intravenous immunoglobulin administration in vivo","volume":"84","author":"Aukrust P.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_22_2","first-page":"229","volume-title":"Inflammation: basic principles and clinical correlates","author":"Nathan C.","year":"1988"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830160709"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4049\/jimmunol.143.4.1210","article-title":"IL\u20102 and IFN\u2010\u03b3 are two necessary lymphokines in the development of cytotoxic T cells","volume":"143","author":"Maraskovsky E.","year":"1989","journal-title":"J. Immunol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.164.6.2113"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.164.5.1791"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.4049\/jimmunol.140.10.3473","article-title":"Regulation of tumor necrosis factor\/cachectuin and IL\u20101 secretion in human mononuclear phagocytes","volume":"140","author":"Burchett S K","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00920238"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.1.133"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.4049\/jimmunol.143.11.3517","article-title":"IL 6 inhibits lipopolysaccharide\u2010induced tumor necrosis factor production in cultured human monocytes, U 937 cells, and in mice","volume":"143","author":"Aderka D.","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood.V75.1.40.40","article-title":"Correlations and interactions in the production of interleukin 6 (IL\u20106), IL\u20101, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL\u20106 suppresses IL\u20101 and TNF","volume":"75","author":"Schindler R.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90036-P"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/iai.58.5.1384-1390.1990","article-title":"Supression of tumor necrosis factor alpha production by human immunoglobulin preparation for intravenous use","volume":"58","author":"Shimozato T.","year":"1990","journal-title":"Infect Immun"},{"key":"e_1_2_1_34_2","first-page":"463","article-title":"Acute inflammation and a Shwartzman\u2010like reaction induced by interleukin\u20101 and tumor necrosis factor. Synergistic actions of the cytokines in the induction of the inflammation and microvascular injury","volume":"129","author":"Movat H Z","year":"1987","journal-title":"Am J Pathol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92146-3"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470100067035"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.145.9.2920","article-title":"The role of IFN\u2010\u03b3 in the pathology of experimental endotoxemia","volume":"145","author":"Heinzel F P.","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.142.5.1500","article-title":"Heterogenous effects of IFN \u03b3 in adjuvant arthritis","volume":"142","author":"Jacob C O","year":"1989","journal-title":"J Immunol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/309799a0"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180502"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.14.5572"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830171228"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0676.1997.tb01032.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0676.1997.tb01032.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T17:52:35Z","timestamp":1698429155000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0676.1997.tb01032.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1111\/j.1600-0676.1997.tb01032.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0676.1997.tb01032.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}